Target intelligence / Profile preview

Ribosomal protein L28 pseudogene

Molecular classification: Pseudogene, Ribosomal protein pseudogene, Other (not enzyme, receptor, transporter, etc.)

Overview

This entry refers to a processed pseudogene derived from the RPL28 gene, which encodes ribosomal protein L28, a component of the large 60S ribosomal subunit involved in protein synthesis[1][2][3]. Pseudogenes are non-coding DNA sequences resembling functional genes but typically lack biological or physiological function due to disabling mutations[5][7]. The ribosomal protein L28 pseudogene is not expressed as a protein and has no known role in cellular processes, signaling, or disease. It is not considered a drug target, nor does it have any established biological, therapeutic, or safety relevance.

Other names: RPL28 pseudogeneRibosomal protein L28 processed pseudogeneENSG00000240934 (Ensembl identifier)

Mechanism of action

None (not targeted by drugs; no mechanism of action relevant).

Biological functions

Generally none (pseudogenes are typically non-functional)Rarely, some pseudogenes have regulatory roles, but no evidence exists for this pseudogene.

Disease associations

None established (not implicated in disease or pathology)Not known to be a biomarker or risk factor.

Safety considerations

None (not a therapeutic target; no safety concerns reported)

Interacting drugs

None (pseudogenes are not drug targets and do not interact with therapeutics directly)

Biomarkers

None (not used as a biomarker for diagnosis or therapy)

Beyond the preview

Go deeper on Ribosomal protein L28 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L28 pseudogene.

Explore the full profile